EP 3116872 A1 20170118 - COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS
Title (en)
COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS
Title (de)
KOMBINATIONSTHERAPIE MIT GLUTAMINASEHEMMERN
Title (fr)
POLYTHÉRAPIE AVEC DES INHIBITEURS DE GLUTAMINASE
Publication
Application
Priority
- US 201461953525 P 20140314
- US 2015020452 W 20150313
Abstract (en)
[origin: US2015258082A1] The invention relates to methods of treating cancer, myeloproliferative disorders or immunological diseases with a combination of an immunomodulatory agent and a glutaminase inhibitor. The invention further relates to methods of treating cancer, myeloproliferative disorders, or immunological diseases that are resistant to one or more immunomodulatory agents.
IPC 8 full level
C07D 417/06 (2006.01); A61K 31/40 (2006.01); A61K 31/433 (2006.01); A61K 31/44 (2006.01); A61K 31/501 (2006.01); A61K 31/506 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); C07D 209/48 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01)
CPC (source: EP US)
A61K 31/4035 (2013.01 - EP US); A61K 31/4402 (2013.01 - US); A61K 31/454 (2013.01 - EP US); A61K 31/501 (2013.01 - EP US); A61K 31/517 (2013.01 - EP US); A61K 31/573 (2013.01 - US); A61K 45/06 (2013.01 - EP US); A61P 35/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
US 2015258082 A1 20150917; EP 3116872 A1 20170118; EP 3116872 A4 20170830; WO 2015138902 A1 20150917
DOCDB simple family (application)
US 201514657584 A 20150313; EP 15761424 A 20150313; US 2015020452 W 20150313